Dawn Viveash
Overview
Dawn Viveash received $1M in total compensation, including $54K in salary, at Orexigen Therapeutics in 2009.
Source: SEC filing on April 28, 2010.
Related executives
We found 13 more executives who work or worked at Orexigen Therapeutics.
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
Thomas Cannell
Orexigen Therapeutics
Chief Operating Officer
Thomas Lynch
Orexigen Therapeutics
General Counsel
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
Preston Klassen
Orexigen Therapeutics
Executive Vice President, Global Product Development
Heather Turner
Orexigen Therapeutics
General Counsel
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer outgoing
Graham Cooper
Orexigen Therapeutics